These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27352187)
1. Non-canonical NF-κB Plays a Pivotal Role in Non-Hodgkin's Lymphoma. Liu M; Song W; Zhang J; Sun M; Sun X; Yu Q Cell Biochem Biophys; 2015 Jul; 72(3):681-5. PubMed ID: 27352187 [TBL] [Abstract][Full Text] [Related]
2. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors. Shen X; Wang M; Guo Y; Ju S Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945 [TBL] [Abstract][Full Text] [Related]
3. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway. Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512 [TBL] [Abstract][Full Text] [Related]
4. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively. Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins. Kohno T; Daa T; Otani H; Shimokawa I; Yokoyama S; Matsuyama T Genes Cells; 2008 Oct; 13(10):1061-73. PubMed ID: 18775026 [TBL] [Abstract][Full Text] [Related]
6. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926 [TBL] [Abstract][Full Text] [Related]
7. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394 [TBL] [Abstract][Full Text] [Related]
8. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation. Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183 [TBL] [Abstract][Full Text] [Related]
9. Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells. Woo YJ; Yoon BY; Jhun JY; Oh HJ; Min SW; Cho ML; Park SH; Kim HY; Min JK Exp Mol Med; 2011 Jun; 43(6):350-7. PubMed ID: 21515993 [TBL] [Abstract][Full Text] [Related]
10. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells. Shen X; Zhu W; Zhang X; Xu G; Ju S Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696 [TBL] [Abstract][Full Text] [Related]
11. Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells. Yu M; Chen Y; He Y; Podd A; Fu G; Wright JA; Kleiman E; Khan WN; Wen R; Wang D J Immunol; 2012 Dec; 189(11):5185-93. PubMed ID: 23087406 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene. Yuan H; Wang Y; Wu X; Wang H; Pu J; Ding W; Wang M; Shen X; Cong H; Zhang L; Zhang M; Ju S DNA Cell Biol; 2010 Mar; 29(3):133-9. PubMed ID: 20025535 [TBL] [Abstract][Full Text] [Related]
13. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303 [TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of B cell-activating factor of TNF family (BAFF) and B cell lymphoma/leukemia-2 (BCL-2) in multiple myeloma]. Wang SM; Zhang TL; Jiang YM; Wu HY; Hao LM; Xing XH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):395-8. PubMed ID: 21518495 [TBL] [Abstract][Full Text] [Related]
15. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. Proust A; Rincé P; Creidy R; Lazure T; Joab I; Garçon L; Fabre M; Guettier C; Raphael M Am J Pathol; 2011 Oct; 179(4):1630-7. PubMed ID: 21871426 [TBL] [Abstract][Full Text] [Related]
16. BAFF is involved in the pathogenesis of IgA nephropathy by activating the TRAF6/NF‑κB signaling pathway in glomerular mesangial cells. Cao Y; Lu G; Chen X; Chen X; Guo N; Li W Mol Med Rep; 2020 Feb; 21(2):795-805. PubMed ID: 31974601 [TBL] [Abstract][Full Text] [Related]
17. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis. Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071 [TBL] [Abstract][Full Text] [Related]
18. BAFF-R gene induced by IFN-γ in multiple myeloma cells is related to NF-κB signals. Shen X; Zhang X; Xu G; Ju S Cell Biochem Funct; 2011 Aug; 29(6):513-20. PubMed ID: 21744373 [TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention. Jazirehi AR; Bonavida B Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036 [TBL] [Abstract][Full Text] [Related]
20. Roles of TRAFs in NF-κB signaling pathways mediated by BAFF. Tang X; Zhang L; Wei W Immunol Lett; 2018 Apr; 196():113-118. PubMed ID: 29378215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]